Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial
Aims Cardiac implantable electronic device (CIED) surgery is commonly performed in
patients with atrial fibrillation (AF). The current analysis was undertaken to compare peri …
patients with atrial fibrillation (AF). The current analysis was undertaken to compare peri …
Comparison of Dabigatran and Uninterrupted Warfarin in Patients With Atrial Fibrillation Undergoing Cardiac Rhythm Device Implantations–Case-Control Study–
J Kosiuk, E Koutalas, M Doering, S Nedios… - Circulation …, 2014 - jstage.jst.go.jp
Background: The incidence of postoperative complications following pacemaker or
implantable cardioverter-defibrillator implantations in patients treated with new oral …
implantable cardioverter-defibrillator implantations in patients treated with new oral …
Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices
CP Rowley, ML Bernard, WW Brabham… - The American Journal of …, 2013 - Elsevier
The perioperative bleeding risk associated with therapeutic anticoagulation at cardiac
implantable electronic device implantation has previously been demonstrated to vary by the …
implantable electronic device implantation has previously been demonstrated to vary by the …
Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations
J Kosiuk, E Koutalas, M Doering, P Sommer, S Rolf… - Europace, 2014 - academic.oup.com
Aims The safety and efficacy of novel oral anticoagulants in patients with atrial fibrillation
undergoing pacemaker or implantable cardioverter-defibrillator interventions have not been …
undergoing pacemaker or implantable cardioverter-defibrillator interventions have not been …
[HTML][HTML] Safety of anticoagulation with uninterrupted warfarin vs. interrupted dabigatran in patients requiring an implantable cardiac device
S Madan, P Muthusamy, KL Mowers… - Cardiovascular …, 2016 - ncbi.nlm.nih.gov
Background The optimal strategy of peri-procedural anticoagulation in patients undergoing
permanent cardiac device implantation is controversial. Our objective was to compare the …
permanent cardiac device implantation is controversial. Our objective was to compare the …
Dabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively: DAWA pilot study
AR Duraes, P de Souza Roriz, B de Almeida Nunes… - Drugs in R&D, 2016 - Springer
Objectives Dabigatran is a direct thrombin inhibitor shown to be an effective alternative to
warfarin in patients with non-valvular atrial fibrillation (AF). We evaluated the use of …
warfarin in patients with non-valvular atrial fibrillation (AF). We evaluated the use of …
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation …
Background—Dabigatran reduces ischemic stroke in comparison with warfarin; however,
given the lack of antidote, there is concern that it might increase bleeding when surgery or …
given the lack of antidote, there is concern that it might increase bleeding when surgery or …
Anticoagulation management in the perioperative phase of implantable cardioverter defibrillator implantation
H Yokoshiki, H Mitsuyama, M Watanabe… - Circulation …, 2013 - jstage.jst.go.jp
Background: According to the current guidelines, substitution of warfarin with heparin is
recommended as perioperative management in patients with high risk of thromboembolism …
recommended as perioperative management in patients with high risk of thromboembolism …
Urgent surgery or procedures in patients taking dabigatran or warfarin: analysis of perioperative outcomes from the RE-LY trial
JD Douketis, JS Healey, M Brueckmann… - Thrombosis …, 2016 - Elsevier
Background There is concern about the management of anticoagulated patients with atrial
fibrillation (AF) who require an urgent surgery/procedure, especially in those who are …
fibrillation (AF) who require an urgent surgery/procedure, especially in those who are …
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE …
Aims Guidelines recommend warfarin continuation rather than heparin bridging for
pacemaker and defibrillator surgery, after the BRUISE CONTROL trial demonstrated an 80 …
pacemaker and defibrillator surgery, after the BRUISE CONTROL trial demonstrated an 80 …